Date published: 2025-10-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

NAALADL2 Antibody (1G5): sc-517173

5.0(1)
Write a reviewAsk a question

Datasheets
  • NAALADL2 Antibody (1G5) is a mouse monoclonal IgG2a κ NAALADL2 antibody provided at 100 µg/ml
  • raised against amino acids 696-795 representing partial length NAALADL2 of human origin
  • recommended for detection of NAALADL2 of human origin by WB, IP and ELISA
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for NAALADL2 Antibody (1G5). This work is in progress.

    QUICK LINKS

    SEE ALSO...

    NAALADL2 Antibody (1G5) is a mouse monoclonal IgG2a kappa light chain antibody that detects NAALADL2 of human origin by western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). Anti-NAALADL2 antibody (1G5) is available as a non-conjugated monoclonal isotype antibody. NAALADL2, or N-acetylated alpha-linked acidic dipeptidase-like 2, is a 795 amino acid single-pass type II membrane protein that belongs to the peptidase M28 family and M28B subfamily. NAALADL2 is primarily located in the cell membrane, which is crucial for potential role in cellular signaling and interaction with extracellular substrates. Membrane localization allows NAALADL2 to participate in various physiological processes, including neuropeptide metabolism and modulation of synaptic transmission, which are vital for maintaining normal neurological function. NAALADL2 exists in two alternatively spliced isoforms and is predominantly expressed in the placenta and kidney, with additional expression noted in certain embryonic tissues. The gene encoding NAALADL2 is situated on human chromosome 3, a region associated with numerous genetic diseases and key tumor suppressor genes, highlighting potential implications of NAALADL2 in both health and disease.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    NAALADL2 Antibody (1G5) References:

    1. The molecular genetics of Marfan syndrome and related microfibrillopathies.  |  Robinson, PN. and Godfrey, M. 2000. J Med Genet. 37: 9-25. PMID: 10633129
    2. Mapping of the CCXCR1, CX3CR1, CCBP2 and CCR9 genes to the CCR cluster within the 3p21.3 region of the human genome.  |  Maho, A., et al. 1999. Cytogenet Cell Genet. 87: 265-8. PMID: 10702689
    3. [New tumor suppressor genes in hot spots of human chromosome 3: new methods of identification].  |  Braga, EA., et al. 2003. Mol Biol (Mosk). 37: 194-211. PMID: 12723467
    4. Plasticity of human chromosome 3 during primate evolution.  |  Tsend-Ayush, E., et al. 2004. Genomics. 83: 193-202. PMID: 14706448
    5. A giant novel gene undergoing extensive alternative splicing is severed by a Cornelia de Lange-associated translocation breakpoint at 3q26.3.  |  Tonkin, ET., et al. 2004. Hum Genet. 115: 139-48. PMID: 15168106
    6. Comparative cytogenetics of human chromosome 3q21.3 reveals a hot spot for ectopic recombination in hominoid evolution.  |  Yue, Y., et al. 2005. Genomics. 85: 36-47. PMID: 15607420
    7. Methylation of the tumor suppressor gene RASSF1A in human tumors.  |  Pfeifer, GP. and Dammann, R. 2005. Biochemistry (Mosc). 70: 576-83. PMID: 15948711
    8. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.  |  Nair, PN., et al. 2007. Cancer Genet Cytogenet. 174: 100-10. PMID: 17452250
    9. Mutilating neuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family.  |  De Jonghe, P., et al. 1997. J Neurol Neurosurg Psychiatry. 62: 570-3. PMID: 9219740

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    NAALADL2 Antibody (1G5)

    sc-517173
    100 µg/ml
    $316.00